Our physician office business for medical and laboratory products is now part of Henry Schein Medical — the world’s largest provider of health care products and services for office-based medical, dental, and animal health practitioners.
Cardinal Health is prepared to meet the newly updated FDA reclassification requirements and provide you with a portfolio of influenza testing platforms that address a variety of needs. From lateral flow to molecular testing, we have a solution that will ensure FDA compliance.
Quidel’s Solana Instrument and Solana Influenza A+B Assay offer a scalable and flexible molecular solution for influenza testing that delivers highly accurate molecular results in an actionable timeframe.
Cardinal Health Lab Briefings is an educational webinar series that provides clinical insights, industry information, and hot topic updates across a variety of diagnostic related issues. Cardinal Health sponsors these webinars with support from leading industry experts and opinion leaders. Receive CE credits by watching past and upcoming webinars at no cost.
What does the FDA reclass of Rapid Influenza Diagnostic Tests mean for you?
With the new guidelines and controls in place, Cardinal Health is well-positioned to meet the newly updated FDA requirements and provide you with a portfolio of influenza testing platforms that address a variety of needs.